Title

Development of AZD5363, an inhibitor of AKT with activity in tumours containing mutations in the P13K-AKT pathway

Speaker:

Dr Barry Davis, AstraZeneca

Date & Time:

Monday, 2 November 2015, 11:00

Location: 
Old Road Campus Research Building, 71A, B and C, Headington OX3 7DQ
Host: 
Department of Oncology
About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
Research
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.